✦ LIBER ✦

Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts

✍ Scribed by Joan Figueras; Martin Prieto; Angel Bernardos; Antoni Rimola; Francisco Suárez; Jorge Ortiz De Urbina; Valentín Cuervas-Mons; Manuel de la Mata

Book ID: 110916697
Publisher: Springer
Year: 2006
Tongue: English
Weight: 117 KB
Volume: 19
Category: Article
ISSN: 0934-0874
DOI: 10.1111/j.1432-2277.2006.00326.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A “Steroid-Free” Tacrolimus and Low-Dose

A “Steroid-Free” Tacrolimus and Low-Dose Mycophenolate Mofetil Primary Immunosuppression Does Not Prevent Early Acute Rejection After Liver Transplantation

✍ P. Reggiani; M. Arru; M. Regazzi; S. Gatti; M.D. Molinaro; L. Caccamo; U. Maggi; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Efficacy and safety of daclizumab induct

Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

✍ G Ciancio; G.W Burke; K Suzart; A Vaidya; D Roth; W Kupin; A Mattiazzi; A Rosen; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Regimen of Tacrolimus-Based Immunosuppre

Regimen of Tacrolimus-Based Immunosuppression With Basiliximab, Mycophenolate Mofetil, and Low-Dose Steroid Reduces Acute Rejection in Kidney Transplants

✍ K. Hoshinaga; A. Aikawa; M. Murai; H. Yamamoto; N. Hirayama; S. Shishido; A. Has 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 67 KB